Kezolid 600 Tablets | Linezolid 600mg for Resistant Bacterial Infections

Kezolid 600 Tablets contain Linezolid, a potent oxazolidinone antibiotic indicated for the treatment of serious Gram-positive bacterial infections, including those caused by resistant strains such as MRSA and VRE.

Linezolid works by inhibiting bacterial protein synthesis, effectively preventing bacterial growth and replication. With excellent oral bioavailability and the ability to switch seamlessly from IV to oral therapy, Kezolid provides flexible and reliable treatment for severe infections in both hospital and outpatient settings.

🔹 Key Benefits

• Effective against resistant Gram-positive infections

• Active against MRSA and VRE

• Rapid reduction in bacterial load

• Excellent oral bioavailability (~100%)

• Enables IV-to-oral switch therapy

• Improves treatment flexibility and outcomes

🔹 Indications

• Complicated skin and soft tissue infections

• Hospital-acquired pneumonia

• Community-acquired pneumonia (Gram-positive)

• Infections caused by MRSA

• Infections caused by VRE